Skip to Main Content

As demands for diversity and equity increase across the globe, a new analysis finds nearly 75% of patients who are enrolled in industry-sponsored clinical trials in academic medical centers and community hospitals are white.

Yet the proportion of a given race or ethnicity among clinical trial personnel closely aligns with the corresponding race or ethnicity of study participants, according to the Center for Study of Drug Development at Tufts University, which conducted the analysis of nearly 3,200 trial sites that are regulated by the Food and Drug Administration.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment